APA (7th ed.) Citation

Shimazu, Y., Kanda, J., Kosugi, S., Ito, T., Kaneko, H., Imada, K., . . . Adachi, Y. (2023). Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin. Scientific Reports, 13(1), 1. https://doi.org/10.1038/s41598-023-32426-6

Chicago Style (17th ed.) Citation

Shimazu, Yutaka, et al. "Efficacy of Elotuzumab for Multiple Myeloma in Reference to Lymphocyte Counts and Kappa/lambda Ratio or B2 Microglobulin." Scientific Reports 13, no. 1 (2023): 1. https://doi.org/10.1038/s41598-023-32426-6.

MLA (9th ed.) Citation

Shimazu, Yutaka, et al. "Efficacy of Elotuzumab for Multiple Myeloma in Reference to Lymphocyte Counts and Kappa/lambda Ratio or B2 Microglobulin." Scientific Reports, vol. 13, no. 1, 2023, p. 1, https://doi.org/10.1038/s41598-023-32426-6.